Basics & Regulatory Requirements  /  Overview and Step in into the field of Biotechnology  /
Process Overview: From Manufacturing of APIs to Fill&Finish  /  Regulations & Challenges for ATMPs


Target Group

This course is addressed to all people interested in pharmaceutical biotechnology related to GMP manufacturing, analytics, product release and marketing authorisation.

Objectives

From a historical view, biopharmaceuticals & biosimilars are no new business. Antibiotics and vaccines have been well known for more than 60 years. But with the marketing authorisation of the first biopharmaceutical product, produced by gene technology in the 80s, a new era of biopharmaceutical and biotechnological development and manufacturing started.

Future pharmaceutical products based on biotechnology and Biosimilars as well as Biologics will become more and more important and present a higher share of pharmaceutical products.

This course will provide non-Biotechnologists with an overview and insight in pharmaceutical biotechnology. It will also present the opportunities of biotechnology in GMP manufacturing and quality control.

Common aspects of product analytics will be discussed just as well as regulatory aspects of Biopharmaceuticals (bacteria, yeast and cell culture) and specific requirements on clinical studies and marketing authorisation. It will furthermore focus on topics like virus clearance reduction, cell banking, media fills and on dedicated rooms and personnel. The course will be completed by a presentation of the current comprehensive bodies of Legislation.


Programme

What is Biotechnology - Introduction to the World of Biotechnology
  • What is biotechnology
  • Historical and modern applications of biotechnology
  • Key Technologies
  • Medical and economic impact
 Regulatory Requirements and Guidelines for Manufacturing Biopharmaceuticals
  • Legal framework on biopharmaceuticals in the EU
  • Guidelines (EU, US, ICH, etc.)
  • Expectations and inspection findings
Manufacturing of Biotechnological APIs – Focus on Cell Culture Technologies and their Products
  • Cell lines as production platforms
  • The manufacturing process (cell culture, harvest, purification)
  • In-process control and release Analytics
  • Quality & regulatory aspects
 Virus Reduction
  • Regulatory background
  • Relevant virus clearance studies and model viruses
  • Common and new methods of virus reduction
  • TSE Safety
Manufacturing of Biotechnological APIs – Focus on bacteria & yeast (E. coli / S. cerevisiae)
  • Suitability of raw materials and consumables
  • Media and buffers
  • Water as raw material
  • Fermentation
  • Cell harvesting
  • Purification
GMP Requirements for Rooms and Personnel
  • Regulatory requirements
  • Balancing GMP and laws of gene Technology
  • Zone Concept
  • Flow of material and personnel
  • Clean Rooms
  • Cleaning and hygiene procedures
  • Monitoring and validation
GMP Requirements for Master and Working Cell Banks (MCB/WCB)
  • From initial cell to final production cell
  • Establishing of cell banks
  • Where does GMP start during cell banking
  • Storage of cell banks
  • Maintenance of cell banks
Fill & Finish of Biotechnological Products
  • Aseptic processing and media fill
  • Liquid formulation or lyophilisation?
  • Stability tests of biopharmaceuticals
ATMPs - Regulations & Challenges
  • Classification of ATMPs
  • Regulatory landscape
  • GMPs for ATMPs
Microbiological Aspects of Biotechnological API Manufacturing
  • Microbiological control of the manufacturing process
  • QC methods (Bioburden, Endotoxins)
  • Handling of contamination events


Further Information

Venue
Qube Hotel Bahnstadt
Grüne Meile 21
69115 Heidelberg, Germany
Phone +49 (0) 6221 18799 0
bahnstadt@qube-heidelberg.de
 
Accommodation
CONCEPT HEIDELBERG has reserved a limited number of rooms in the conference hotel. You will receive a room reservation form/POG when you have registered for the conference. Reservation should be made directly with the hotel. Early reservation is recommended.

Fees (per delegate, plus VAT)
ECA Members € 1,890
APIC Members € 1,990
Non-ECA Members € 2,090
EU GMP Inspectorates € 1,045
The fee is payable in advance after receipt of invoice and includes dinner on the first day, lunch on both days, and all refreshments. VAT is reclaimable.

Presentations/Certificate
The presentations for this event will be available for you to download and print before and after the event. Please note that no printed materials will be handed out on site and that there will not be any opportunity to print the presentations on site. After the event, you will automatically receive your certificate of participation.

Conference language
The official conference language will be English.

Social Event
On the evening of the first course day, the participants are cordially invited to a dinner. This event is an excellent opportunity to share your experiences with colleagues from other companies in a relaxed atmosphere.
 
Contacts
Questions regarding content:
Mr Clemens Mundo (Operations Director), +49 (0) 6221 84 44 42, mundo@concept-heidelberg.de
Questions regarding organisation:
Ms Julia Grimmer (Organisation Manager), +49 (0) 6221 84 44 44, julia.grimmer@concept-heidelberg.de


Date & Time

Tue, 20 October 2026, 9:00 h – 17:00 h
(Registration and coffee 8:30 – 9:00 h)
Wed, 21 October 2026, 8:30 h – 15:30 h

Costs

ECA-Member*: € 1890,-
Non ECA Member*: € 2090,-
EU/GMP Inspectorates*: € 1045,-
APIC Member Discount*: € 1990,-

(All prices excl. VAT). Important notes on sales tax.

* also payable by credit card
American Express Visa Mastercard

icon
Additional dates on-site
Additional dates on-site
not available
icon
Additional dates online
Additional dates online
not available
icon
Recording
Not available
stop

This course is part of the GMP Certification Programme "ECA Certified Biotech Manager"

Do you have any questions?

Please contact us:
Tel.: +49 6221 8444-0
E-Mail: info@gmp-compliance.org

Woman with headset

Go back

Testimonials about our courses and conferences

"Great material and speakers" and "Great speakers a lot of experience and sharing"

Felipe Gonzalez, Mucos Emulsionsgesellschaft mbH
Live Online Training - Granulation & Tableting, September 2024

“I found the course eye opening and very well organized.”

Jozsef Maklary, Veolia Industries Austria GmbH
The GMP-Compliance Manager, October 2025

"I am so grateful for having attended this course. Great job from all, and very profitable. Thanks!”

Alba Aranda Cuesta, Kern Pharma
KPIs and Quality Metrics, Berlin, Germany, April 2025

"The lectures were very informative, interesting and entertaining."

Albert Godoy Hernández, Company synaffix
Live Online Training - GMP Auditor Practice, October 2024

"Really useful training which I will use in my daily work."

Regina Mommaerts, Galapagos NV
Live Online Training - GMP Auditor Practice, October 2024

"Wonderful format of the sessions: Good range of participations and experience in the team. Would love to attend another one soon."

Roopasi Mathi, Wacker Biotech B.V.
Live Online Training - GMP Auditor Practice, October 2024

"Very good balance between general and detailed information"

Dr Ralf Albrecht, Tillotts Pharma AG
Live Online Training - Granulation & Tableting
September 2024

"Nice presentations: easy understanding, quite visual"

Susana Manrique, Boehringer Ingelheim España, S.A,
Live Online Training - Granulation & Tableting, September 2024

“Fantastic course – I really enjoyed the interactive structure & greatly appreciate social activity.”

Anthony Cummins, Sebela Pharmaceuticals, Ireland
GMP Auditor Practice, September 2023

 

“Very well organized, information on point without being overwhelming.”

Eleni Kallinikou, Pharmathen
Live Online Trainng - Pharmaceutical Contracts - Febuary 2024

 

“Good overview of different types of agreements, good to see both the GMP and the legal angle”

Ann Michiels, Johnson&Johnson
Live Online Trainng - Pharmaceutical Contracts, Febuary 2024

 

 

“Both, organizers and lecturers were very friendly, open for discussions and extremely constructive. The course was a valuable experience for me.”

Maria Dimitrova, NKN Law Firm
Pharmaceutical Contracts: GMP and Legal Compliance, March 2025